85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05255991 (ClinicalTrials.gov)	October 4, 2022	15/2/2022	Multinational Study of Efficacy and Safety of Inhaled Treprostinilin Subjects With Idiopathic Pulmon ...	A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Saf ...	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Placebo;Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Recruiting	40 Years	N/A	All	396	Phase 3	Argentina;Australia;Chile;Denmark;France;Israel;Korea, Republic of;Mexico;Spain;Taiwan
2	EUCTR2021-005881-17-DK (EUCTR)	12/09/2022	15/07/2022	A study evaluating the efficacy and safety of inhaled treprostinilin subjects with idiopathic pulmon ...	A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Saf ...	Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Trade Name: TYVASO® (treprostinil) inhalation solution, for oral inhalation use Product Name: Trepros ...	UNITED THERAPEUTICS CORPORATION	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	396	Phase 3	Taiwan;Spain;Chile;Israel;United Kingdom;Italy;France;Mexico;Argentina;Belgium;Denmark;Australia;Per ...
3	NCT04905693 (ClinicalTrials.gov)	September 6, 2022	20/5/2021	Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Enrolling by invitation	40 Years	N/A	All	792	Phase 3	United States
4	NCT04708782 (ClinicalTrials.gov)	June 1, 2021	12/1/2021	Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled ...	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Placebo;Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Recruiting	40 Years	N/A	All	396	Phase 3	United States
5	NCT00705133 (ClinicalTrials.gov)	July 2008	23/6/2008	TreprostinilTherapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypert ...	Using Either Intravenous (IV) or Subcutaneous (SQ) Treprostinilto Treat Pulmonary Hypertension Relat ...	Pulmonary Arterial Hypertension;Interstitial Lung Disease;Idiopathic Pulmonary Fibrosis	Drug: Treprostinil	Rajan Saggar	United Therapeutics	Completed	N/A	N/A	All	15	Phase 2	United States
6	NCT00703339 (ClinicalTrials.gov)	June 2008	19/6/2008	Effects of Inhaled TreprostinilSodium for the Treatment of Pulmonary Hypertension Associated With Id ...	A Single-Dose, Dose-Escalating Study Exploring the Safety, Pharmacokinetics, and Pharmacodynamic Eff ...	Idiopathic Pulmonary Fibrosis;Pulmonary Hypertension	Drug: Treprostinil sodium for inhalation	Lung Biotechnology PBC	NULL	Terminated	35 Years	80 Years	All	1	Phase 2	United States

First Previous1Next Last